ANET vs MRK: Which Is the Better Buy?
Side-by-side comparison of Arista Networks, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-06.
Arista Networks, Inc. · Technology
$169.86
+22.0% upside to fair value
Grade B
High Quality
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
ANET has more upside to fair value
(+22.0%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ANET |
MRK |
| Current Price |
$169.86 |
$113.87 |
| Fair Value Estimate |
$207.23 |
$100.14 |
| Upside to Fair Value |
+22.0%
|
-12.1%
|
| Market Cap |
$213.9B |
$281.2B |
| Forward P/E |
56.5x
|
32.0x
|
| EV / EBITDA |
44.7x
|
17.3x
|
| Price / Sales |
21.7x
|
4.3x
|
| Price / FCF |
39.9x
|
19.9x
|
| Revenue Growth YoY |
+35.1%
|
+4.3%
|
| Gross Margin |
63.5%
|
75.9%
|
| Operating Margin |
42.8%
|
27.6%
|
| Return on Equity |
30.6%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.51%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Arista Networks is a leading provider of cloud and AI data-center switching solutions with a durable competitive moat driven by its strong presence among hyperscale cloud customers and AI networking providers. The company benefits from a seasoned management team led by founding CEO Jayshree V. Ullal, who has over 17 years at the helm and deep domain expertise. Arista's financials show robust grow…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
ANET |
MRK |
| Zone Low |
$155.42 |
$75.11 |
| Zone High |
$176.15 |
$85.12 |
| In Buy Zone? |
Yes
|
No
|